DIAPH3 and glioblastoma: According to TCGA, 36% of glioblastoma patients harbor copy number alterations of DIAPH3, most of which (35%) are copy losses (Figure 1A), whereas only 1% of these patients have a mutation in DIAPH3 (Figure 1B).